Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Flotation

Compass navigates IPO
Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.
Amwell rams its way to $742m IPO
The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Outset Medical pumps IPO up to $278m
The kidney dialysis technology provider has added about $36m to close its initial public offering, it shares having more than doubled in price.
JFrog jumps IPO up to $509m
Dell's stake in the software release technology provider is sized at almost $490m following an initial public offering in which it floated well above its range.
Metacrine shows mettle in $85m IPO
Lilly Asia Ventures achieved an exit as the gastrointestinal and liver disease drug developer priced its initial public offering in the middle of its range.
Snowflake hits public markets in $3.36bn IPO
Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.
Opendoor welcomes reverse merger
Lennar, SoftBank, Access Industries and Alphabet are set to score exits from the real estate transaction manager, valued at $4.8bn in the deal.
Outset Medical outpaces expectations in $242m IPO
Baxter International scored an exit as dialysis machine developer Outset Medical floated above its range in an upsized offering.

Other News

Hymson lasers its way to $107m IPO
The laser manufacturing equipment maker is going public on Shanghai's Star Market two years after a Legend Capital-backed seed round.
Xpeng extracts $1.5bn from initial public offering
The Alibaba, Xiaomi, Foxconn, UCar and Duowan-backed smart electric carmaker has floated in the US through an offering valuing it in excess of $21bn.
Desktop Metal irons out $2.5bn reverse merger
Desktop Metal, backed by a large consortium of corporates, will merge with special purpose acquisition company Trine to list on the NYSE at a $2.5bn valuation.
Metacrine sets off for $100m IPO
Gastrointestinal and liver disease-focused Metacrine has filed to go public having raised $125m from investors including Eli Lilly.
Luminar to enter limelight through reverse merger
Volvo Cars, Corning and Cornes-backed lidar technology developer Luminar is merging with a special purpose acquisition vehicle to form a company with an expected $3.4bn valuation.
Nano-X nabs $165m in initial public offering
The SK Telecom, iA Financial, Foxconn and Fujifilm-backed X-ray technology developer priced the offering at the top of its range.

Editor's Picks

Amwell rams its way to $742m IPO
The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Snowflake hits public markets in $3.36bn IPO
Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.
Opendoor welcomes reverse merger
Lennar, SoftBank, Access Industries and Alphabet are set to score exits from the real estate transaction manager, valued at $4.8bn in the deal.
Xpeng extracts $1.5bn from initial public offering
The Alibaba, Xiaomi, Foxconn, UCar and Duowan-backed smart electric carmaker has floated in the US through an offering valuing it in excess of $21bn.
test reg

Login